Centiva Capital, LP Amgen Inc Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Amgen Inc stock. As of the latest transaction made, Centiva Capital, LP holds 81 shares of AMGN stock, worth $22,704. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1,987 95.92%

Holding current value

$22,704

Previous $620,000 95.81%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $589,678 - $643,046	-1,906 Reduced 95.92%	81 $26,000
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $522,084 - $634,468	1,987 New	1,987 $620,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $1.31 Million - $1.47 Million	-5,108 Reduced 81.4%	1,167 $336,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $610,252 - $757,644	2,791 Added 80.11%	6,275 $1.69 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $724,018 - $856,137	3,379 Added 3218.1%	3,484 $773,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $2.14 Million - $2.61 Million	-9,493 Reduced 98.91%	105 $25,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.06 Million - $1.35 Million	4,644 Added 93.74%	9,598 $2.52 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $6.07 Million - $6.84 Million	-27,030 Reduced 84.51%	4,954 $1.12 Million
Q2 2022 Aug 17, 2022	SELL	$230.71 - $256.74 $11.1 Million - $12.4 Million	-48,200 Reduced 60.11%	31,984 $7.78 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $17.1 Million - $19 Million	73,981 Added 1192.66%	80,184 $19.5 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.36 Million - $1.5 Million	6,203 New	6,203 $1.5 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $962,583 - $1.07 Million	-4,121 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $793,993 - $925,270	3,578 Added 658.93%	4,121 $1.03 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $1.27 Million - $1.51 Million	-5,873 Reduced 91.54%	543 $125,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $2.79 Million - $3.1 Million	-11,898 Reduced 64.97%	6,416 $1.63 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $258,735 - $317,503	-1,308 Reduced 6.67%	18,314 $4.32 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $3 Million - $3.98 Million	16,473 Added 523.12%	19,622 $3.98 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $288,356 - $370,636	1,524 Added 93.78%	3,149 $759,000
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $282,928 - $339,007	1,625 New	1,625 $314,000
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $6.3 Million - $7.38 Million	-37,791 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $5.08 Million - $5.72 Million	28,059 Added 288.32%	37,791 $7.18 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $1.74 Million - $2.03 Million	9,732 New	9,732 $1.9 Million

Others Institutions Holding AMGN

# of Institutions

3,083

Shares Held

405M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Amgen Inc Transaction History